Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes

Landman, Gijs W.D., Kleefstra, Nanne, van Hateren, Kornelis J.J., Groenier, Klaas H., Gans, Rijk O.B., Bilo, Henk J.G.·2010·Diabetes Care
DOI 10.2337/dc09-1380

Cited by (503)

Items 401–500 of 503

  1. Pharmacology and safe prescribing of metformin
    Bugewa Apampa · 2012 · Nurse Prescribing
  2. Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015
    Joungyoun Kim, Yoon‐Jong Bae, Jae‐woo Lee, Ye-Seul Kim, Yonghwan Kim, Hyo‐Sun You, Hyeong-Seop Kim, Eun-A Choi, Ye-Eun Han, Hee‐Taik Kang · 2021 · Medicine
  3. A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres
    Tae Hoon Roh, Ji-Hyun Lee, Seo Jin Kim, Jin‐Kyoung Shim, Junseong Park, Seon‐Jin Yoon, Wan‐Yee Teo, Se Hoon Kim, Jong Hee Chang, Seok‐Gu Kang · 2021 · Journal of Neuro-Oncology
  4. High-Concentration Metformin Reduces Oxidative Stress Injury and Inhibits the Growth and Migration of Clear Cell Renal Cell Carcinoma
    Yang Liu, Jianwei Li, Miaomiao Song, Guisong Qi, Lingling Meng · 2022 · Computational and Mathematical Methods in Medicine
  5. Review of Patents for Anticancer Agents Targeting Adenosine Monophosphate-Activated Protein Kinase
    Hyo‐Kyoung Choi, Soo‐Hyun Park, Jangho Lee, Jin‐Taek Hwang · 2023 · Journal of Medicinal Food
  6. Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
    Nai-Yu Lin, Kun-Yu Tsai, Yen‐Lin Huang, Bor‐Kang Jong, Zhen-Hao Yu, Ching-Chung Cheng, Shu-Huan Huang, Jeng‐Fu You, I-Li Lai · 2025 · Scientific Reports
  7. Type II Diabetes, Metformin Use, and Colorectal Neoplasia: Mechanisms of Action and Implications for Future Research
    Jin Ha Lee, Tae Il Kim · 2013 · Current Colorectal Cancer Reports
  8. Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two Cases
    Dimpi Desai, Devika Rao, Vineeth Sukrithan, Eleanor Weinstein, Akankasha Goyal, Ulrich K. Schubart · 2017 · Journal of Investigative Medicine High Impact Case Reports
  9. Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study
    Jing de Haan-Du, Gijs W.D. Landman, Nanne Kleefstra, Dennis Schrijnders, Marjolijn Manders, Amanda C. R. K. Bos, Cathrien S. Tromp-van Driel, Petra Denig, Klaas H. Groenier, Geertruida H. de Bock · 2021 · Cancers
  10. Preventive and (Neo)Adjuvant Therapeutic Effects of Metformin on Cancer
    Yile Jiao, Xiaochen Wang, Zhijun Luo · 2020 · IntechOpen eBooks
  11. Is Host Metabolism the Missing Link to Improving Cancer Outcomes?
    Christopher M. Wright, Anuradha A. Shastri, Emily K. Bongiorno, Ajay Palagani, Ulrich Rodeck, Nicole Lynn Simone · 2020 · Cancers
  12. Considerations Regarding Public Use of Longevity Interventions
    Yasmine J. Liu, Rebecca L. McIntyre, Georges E. Janssens · 2022 · Frontiers in Aging
  13. Targeting Breast Cancer in Diabetic Mice Using a Combination of Thymoquinone and Metformin
    Naeimah S. Sulayman Aboulqassim, Wamidh H. Talib · 2022 · The Natural Products Journal
  14. A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer
    Chung‐Shien Lee, So Yi Lam, Angel Liu, Cristina P. Sison, Xinhua Zhu · 2023 · Clinical Medicine Insights Oncology
  15. Metformin and cancer mortality
    Lev Mikhaylovich Bershteyn · 2010 · Diabetes Mellitus
  16. Putting medications where they belong: Practical advice for managing type 2 diabetes in clinical practice
    Jeff Unger, Debbie Hinnen, Barbara Schreiner, Chris Parkin · 2012 · Journal of the American Academy of Nurse Practitioners
  17. Los nuevos antidiabéticos en el punto de mira… ¿razones de seguridad o caza de brujas?
    Joana Nicolau, Lluís Masmiquel · 2011 · Endocrinología y Nutrición
  18. Risk factors of malignancy
    И. В. Друк, E. V. Semenova, Е. Н. Логинова, Olga Yu. Korennova, Семенкин Александр Анатольевич, Elena A. Lyalyukova, Elena V. Nadey · 2022 · Экспериментальная и клиническая гастроэнтерология
  19. Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function
    Shogo Maruzen, Seiichi Munesue, Mitsuyoshi Okazaki, Satoshi Takada, Shinichi Nakanuma, Isamu Makino, Linxiang Gong, Susumu Kohno, Chiaki Takahashi, Hidehiro Tajima et al. · 2024 · Onco
  20. Diabetes mellitus and cardiovascular diseases
    Terezie Pelikánová · 2011 · Cor et Vasa
  21. Diabetes Alone should not be a Reason for Withholding Adjuvant Chemotherapy for Stage III Colon Cancer
    Maren A. van Waalwijk, Saskia A. M. van de Schans, Harm Reinout Haak, Martine Extermann, Wouter Dercksen, Maryska L.G. Janssen-Heijnen · 2011 · Journal of Comorbidity
  22. Re-Examination of the Sel’kov Model of Glycolysis and Its Symmetry-Breaking Instability Due to the Impact of Diffusion with Implications for Cancer Imitation Caused by the Warburg Effect
    Miljko V. Satarić, Tomas Nemeš, Jack A. Tuszyński · 2024 · Biophysica
  23. The new antidiabetic agents in the firing line… safety reasons or witch hunt?
    Joana Nicolau, Lluís Masmiquel · 2012 · Endocrinología y Nutrición (English Edition)
  24. Metformin
    Snježana Popović‐Pejičić, Valentina Soldat Stanković · 2015 · Cardiovascular Endocrinology
  25. Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study
    Cem Sulu, Ayyüce Begüm Bektaş, Suleyman Sami Guzel, Kubilay Tay, Serdar Şahin, Emre Durcan, Hande Mefkure Özkaya, Pınar Kadıoğlu · 2022 · Growth Hormone & IGF Research
  26. Therapeutic role of metformin and troglitazone to prevent cancer risk in diabetic patients: evidences from experimental studies
    Muhammad Ejaz ul Haq, Muhammad Sajid Hamid Akash, Kanwal Rehman, Mohsin Khurshid · 2020 · Turkish Journal of Biochemistry
  27. Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome
    Ji Soo Park, Soo Jin Moon, Hyung Seok Park, Sang-Hoon Cho · 2024 · Preventive Medicine Reports
  28. Metformin: Its salutary effects beyond diabetes mellitus
    Khalid Sawalha, Nitesh Gautam, Kalaivani Sivakumar, Hakan Paydak, Jawaher L Mehta · 2025 · Journal of Investigative Medicine
  29. The Biology of the Deadly Love Connection Between Obesity, Diabetes, and Breast Cancer
    Bin Bao, Anthony Oraha, Aamir Ahmad, Shadan S. Ali, Yiwei Li, Asfar Sohail Azmi, Sanjeev Banerjee, Fazlul H. Sarkar · 2012 · Springer eBooks
  30. Identification and chemoprevention in subjects at moderate risk of colorectal cancer
    Robert Benamouzig, Bernard Uzzan · 2011 · Best Practice & Research Clinical Gastroenterology
  31. Metformin Use is Associated with Improved Survival in Diabetic Pancreatic Cancer Patients
    S.H. Kim, Minjung Kim, Beodeul Kang, Joong Bae Ahn, Hye Jin Choi · 2014 · Annals of Oncology
  32. Paradigm shift in cancer treatment: Cancer treatment as a metabolic disease – fusion of Eastern and Western medicine
    Reo Hamaguchi, Hiromi Wada · 2017 · Journal of Traditional Chinese Medical Sciences
  33. Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil
    Neslisah Barlak, Fatma Şanli, Özel Çapik, Elanur Tuysuz, Elanur Aydın Karataş, Hasan Türkez, Ömer Faruk Karataş · 2019 · Clinical Cancer Drugs
  34. Metformin and Cancer: Is This the End?
    Emily J. Gallagher, NATHAN G. KASE, Nina A. Bickell, Derek LeRoith · 2022 · Endocrine Practice
  35. New clinical data with metformin therapy in patients with diabetes mellitus
    György Jermendy · 2010 · Orvosi Hetilap
  36. THE EFFECTS OF METFORMIN ON PANCREATIC CANCER METABOLISM
    Mary Jo Cantoria · 2014 · UA Campus Repository (The University of Arizona)
  37. Chemoprevention in Barrett’s Esophagus: An Updated Review
    Sunil Sadruddin Samnani, Janusz A. Jankowski, Paul Moayyedi · 2025 · Gastrointestinal Endoscopy Clinics of North America
  38. Beeinflussen Diabetestherapien das Krebsrisiko?
    Jutta Maria Nagel · 2012 · Der Diabetologe
  39. Non-Insulin Agents for Diabetes
    Gayatri Sreemantula, Santosh H Shankarnarayan · 2012
  40. Metformin Challenges in Advanced Chronic Kidney Disease: A Promising Therapeutic Strategy
    Manuel Fidalgo Díaz, Rafael Alonso Valente, V. Becerra Mosquera, I. Abuward, S. Puello Martínez, N. Ardha, Marta Duran Beloso, Díaz García, T. Cordal Martínez, Dolores Güimil Carbajal et al. · 2017
  41. Traitements hypoglycémiants et cancer
    D. Simon · 2011 · Médecine des Maladies Métaboliques
  42. Correlation between metformin intake and prostate cancer
    Raeun Kim, Minsun Song, Jiwon Shinn, Hun‐Sung Kim · 2023 · Cardiovascular Prevention and Pharmacotherapy
  43. Metformin and mTOR Inhibitors: Allies against Ovarian and Breast Cancers
    Isabella dos Santos Guimarães, Nayara Gusmão Tessarollo, Diandra Zipinotti dos Santos, Marcele Lorentz Mattos de Souza, Taciane Barbosa Henriques, Ian Victor Silva, Letícia Batista Azevedo Rangel · 2017 · Journal of Carcinogenesis & Mutagenesis
  44. Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus
    A.M. Mkrtumyan · 2018 · Meditsinskiy sovet = Medical Council
  45. Metformin and Its Implication in Cancer Therapy
    Laura Mazilu, Dana Lucia Stănculeanu, Andreea Daniela Gheorghe, Adrian‐Paul Suceveanu, Irinel R. Parepa, Felix Voinea, Doina Catrinoiu, Andra‐Iulia Suceveanu · 2019 · IntechOpen eBooks
  46. Pharmacological interventions part IV: Metabolic modifiers
    Tomas Koltai, Stephan J. Reshkin, Salvador Harguindey · 2020 · Elsevier eBooks
  47. Developing new comorbidity indices for cancer populations using administrative data
    Diana Sarfati · 2013 · Otago University Research Archive (University of Otago)
  48. THE METABOLOMIC EFFECTS OF METFORMIN ON COLON CANCER
    Jennifer W. Harris · 2015 · UKnowledge (University of Kentucky)
  49. Targeting the mTOR signalling pathway for prevention and therapy of tuberous sclerosis in mouse models
    Maria Kalogerou · 2013 · ORCA Online Research @Cardiff (Cardiff University)
  50. Emerging concepts in metformin therapy: Hyperglycaemia and beyond
    Tarek M. Fiad, Fatema Al Hammadi, Asma Al Nuaimi, Jamila Al Dhuhouri · 2013 · Ibnosina Journal of Medicine and Biomedical Sciences
  51. Insulin Sensitizers Versus Secretagogues as First‐Line Therapy for Diabetes: Rationale for Clinical Choice
    Robert J. Richards, Lydia Yvonne Melendez-Ramirez, William T. Cefalu · 2011 · Wiley eBooks
  52. An Overview of Metformin and Implications in the Workplace
    Joan S. Grant, Laura A. Steadman · 2015 · Workplace Health & Safety
  53. New Therapies for Diabetes Mellitus
    George T. Griffing · 2012 · Pathy's Principles and Practice of Geriatric Medicine
  54. Quantifying the associations between diabetes mellitus, glycated haemoglobin and incidence of and mortality from cancer: analysis of longitudinal data from England and Scotland linked to Cancer Registry and mortality data
    Vanessa Gordon-Dseagu · 2014 · UCL Discovery (University College London)
  55. Potentsial'nye vozmozhnosti metformina v profilaktike i lechenii onkologicheskikh zabolevaniy u bol'nykh sakharnym diabetom 2 tipa
    Ivan Ivanovich Dedov, С А Бутрова, Marina A. Berkovskaya · 2011 · Obesity and metabolism
  56. Diabetes, Insulin Resistance, and Cancer: An Update
    José María de Miguel-Yanes · 2010 · Current Cardiovascular Risk Reports
  57. Confounding Factors of the Diabetes - Metformin - Cancer Relationship
    Mihaela D. Aldea, Lucian Craeiun, Tiberiu Popescu, Iuliana Nenu, Carmen Bianca Crivii · 2014 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
  58. Metformin: a pharmacological approach integrating hyperinsulinemia breast cáncer at the molecular, cellular clinical levels
    Begoña Martı́n-Castillo, Alejandro Vázquez‐Martín, Cristina Oliveras‐Ferraros, Javier Abel Menéndez · 2010 · Avances en Diabetología
  59. 36th Annual San Antonio Breast Cancer Symposium: resumen de los conceptos clínicos más relevantes
    Joaquín Gavilá, María Dolores Torregrosa, Ángel Guerrero, Regina Gironés, Amparo Ruı́z, Pedro López · 2013 · Revista de Senología y Patología Mamaria
  60. Management of type 2 diabetes mellitus for general practitioners
    AM Klisiewicz, KRL Huddle · 2011 · Journal of Endocrinology Metabolism and Diabetes of South Africa
  61. Cancer et diabète de type 2
    Vincent Durlach · 2011 · Médecine thérapeutique
  62. DIRECT EFFECTS OF METFORMIN ON PI3K AND RAS SIGNALING IN ENDOMETRIAL CANCER
    Iglesias, Antonio David · 2012
  63. EVIDENCES - THREE PRONGED DEFENSE OF BODY AGAINST CANCER CELLS RESULTING IN CARDIAC, METABOLIC AND AUTO-IMMUNE DISORDERS
    Sanjay Dosaj, Ravi Kumar Sharma, Utkarsh Dosaj, Mount Plaza Basement · 2012
  64. Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
    Qiu, Hong · 2011
  65. La metformina inhibe el crecimiento de células de carcinoma de tiroides, suprime la autorrenovación de las células madre del cáncer y potencia el efecto de los agentes quimioterapéuticos
    Dulce Cynthia Fraire González · 2012 · Revista de Endocrinología y Nutrición
  66. A Novel Anti-Diabetic Peptide Nanomedicine Against Pancreatogenic Diabetes
    Amrita Banerjee · 2013 · Figshare
  67. The Way Forward: Translation
    James L. Kirkland, Tamar Tchkonia · 2015 · Springer eBooks
  68. Uso de metformina e a ocorrência de neoplasias em pacientes com Diabetes Mellitus pré-existente
    Tássia Aparecida Martins de Carvalho · 2016 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  69. Advances in the study on metformin beyond its hypoglycemic effect
    Di Yang, Shandong Ye · 2013 · International Journal of Pathology and Clinical Medicine
  70. Primärprävention des Mammakarzinoms
    Sabine Thor-Wiedemann, Günther J. Wiedemann · 2013
  71. Can Metformin Prevent Cancer?
    Salomón Jakubowicz · 2015 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  72. Effects of Metformin on Breast Cancer Risk and Mortality in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
    Pusoon Chun · 2015 · Korean Journal of Clinical Pharmacy
  73. Metformin and Prostate Cancer among Diabetic Men
    David Margel · 2014 · TSpace (University of Toronto)
  74. Growth inhibition by metformin in YD-38 oral cancer cells derived from Korean
    Dong Kuk Seo, Su-Gwan Kim, Dae-San Go, Chun Sung Kim, Sun‐Kyoung Yu, Do Kyung Kim · 2017 · Oral Biology Research
  75. At the intersection of Diabetes and Cancer: the role of angiogenesis and inflammation
    Ana Rita Rocha · 2017 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  76. Плейотропные эффекты метформина: антионкогенное действие (обзор литературы)
    V.І. Pankiv · 2013 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  77. The Prevention and Control of Cancer by Metformin in Patients with Type 2 Diabetes: A Systematic Mapping Review
    Albania Mitchell, Michelle Price, Gabriela C. Cipriano · 2021 · medRxiv
  78. Effect of Metformin in Preventing Insulin-Mediated Proliferation of p53 and Liver Kinase B1 Mutant and Wild-Type Lung Cancer Cell Lines
    Manu Krishnan, Kavita Sahai · 2014 · Journal of Medical Academics
  79. Sympathetic Signaling Mediator, Norepinephrine, Re-Activates Prostate Cancer Bone Metastases through Direct and Indirect Mechanisms
    Ann M. Decker · 2019 · Deep Blue (University of Michigan)
  80. Diabetes with Pancreatic Ductal Adenocarcinoma
    Gowru Srivani, Begum Dariya, Afroz Alam, Ganji Purnachandra Nagaraju · 2019 · Springer eBooks
  81. Orale Antidiabetika im Rahmen der ÖDG-Leitlinien 2009
    Susanne Kaser, Christoph F. Ebenbichler · 2010 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  82. Thérapeutique des désordres glycémiques
    2014 · Elsevier eBooks
  83. Malignancy Concerns With Antidiabetic Therapies: Examining the Evidence
    Harold E. Lebovitz · 2010 · Endocrine Practice
  84. An evaluation of the efficacy of therapeutic approaches to correcting the indices of the systems of coagulation and fibrinolysis, inflammation markers in patients with diabetes mellitus of type 2 with obesity
    K. F. Kehiopulo · 2013 · Bukovinian Medical Herald
  85. Thérapeutique des désordres glycémiques
    2019 · Elsevier eBooks
  86. Current literature in diabetes
    2010 · Diabetes/Metabolism Research and Reviews
  87. Effect of metformin on the prognosis of chemoradiotherapy cancer patients: a systematic review and meta-analysis of randomized controlled trials and cohort studies
    Da Wang, Penglai Zhao, Xiaohua Dong, Haizhong Ma, Miao Yu, Kehu Yang, Hui Cai · 2023 · Research Square
  88. A forgotten dimension of big data in drug repositioning
    Elie Rassy, Fabrice André · 2023 · European Journal of Cancer
  89. Diabetes Mellitus and Cancer
    Melek Çağlayan, Orhan Önder Eren · 2023
  90. The potential of metformin nanoformulations for cancer prevention and therapy
    Seyyedeh Mina Hejazian, Parnia Pouya, Sepideh Zununi Vahed, Elham Dalir Abdollahinia, Parvin Samadi Pakchin, Yasin Bagheri, Hamieh Goshtasbi, Solmaz Maleki Dizaj, Javad Yazdani, Simin Sharifi et al. · 2024 · Journal of Drug Delivery Science and Technology
  91. Cancer and Diabetes: Invited Short Commentary
    2020 · Obesity and Diabetes Research
  92. Metformin: Progress in Research on Antitumor Mechanisms Based on Cellular Energy Metabolism
    小念 陈 · 2024 · Advances in Clinical Medicine
  93. Metformin Adsorption on Binuclear Boron Schiff Complexes
    Marisol Ibarra‐Rodríguez, Victor Manuel Jimenez‐Perez, Blanca M. Muñoz‐Flores, Mario Sánchez · 2025 · Journal of the Mexican Chemical Society
  94. Mechanism of Jianpixiaoke Recipe in Treating Type 2 Diabetes Based on Network Pharmacology and Molecular Docking
    Huan Li, Wenrong An, Chengcheng Huang, Guowei Fang, Yanqin Huang · 2025 · International Journal of Endocrinology
  95. Relationship between breast cancer and metformin: A bibliometric review
    Zhaoning Wang, Fangrui Zhao, Linlin Wang · 2026 · Medicine
  96. OLD DRUG, NEW USES: A COMPREHENSIVE REVIEW OF THE EVOLVING ROLE OF METFORMIN IN ONCOLOGY
    Bernard Myszewski, Maria Rajkowska, Aleksandra Włodarczyk, Norbert Grabias, Jędrzej Piotrowski, Paulina Jarząbek, Julia Weronika Mieszkowska, Radosław Gryko, Anna Kinga Tejchma, Łukasz Dominik Woźniak · 2026 · International Journal of Innovative Technologies in Social Science
  97. Design, synthesis and development of new biguanide-like molecules to circumvent drug resistance in melanoma
    Oleksandr Grytsai · 2018
  98. Low protein diet induced anti-cancer immune response
    Jozef P. Bossowski · 2018 · theses.fr (ABES)
  99. Dual role of metformin as a chemosensitizer and normal tissue protectant: Does it improve the therapeutic ratio? – A narrative review
    Tanisha Gupta, Mohsin Khan, Mohammad Akram, M. A. Bilal Hussain · 2026 · Annals of Oncology Research and Therapy
  100. O-GlcNAcylation is a mitochondrial-nuclear signal that regulates passive transport through the nuclear pore complex
    Talia Hart, Ashley Duke, Yifei Zhou, Alexander A. Soukas, Armen I. Yerevanian · 2026 · Journal of Biological Chemistry